A new clause will be inserted into TCA’s current drug testing policy. It states that the organization supports changes to the Federal Motor Carrier Safety Administration and/or Department of Transportation regulations to permit alternative specimens, such as hair, to be used to comply with federal drug testing requirements.
TCA now supports a policy on sleep disorders which not only addresses a regulation, but also addresses the manner in which it is issued.
First, if FMCSA develops screening and testing standards for sleep disorders, TCA believes the agency should do so only through rulemaking, and not through the publication of regulatory guidance. (This is similar to a new policy adopted by the American Trucking Associations last fall.)
Secondly, TCA will support the development of any future regulation on establishing objective standards for sleep disorder screening, testing and treatment if the regulation: 1) focuses on conditions that pose a substantially elevated crash risk based on sound data and analysis, 2) is cost-beneficial, and 3) promotes effective treatments that minimize the impact to motor carriers and commercial vehicle operators.
TCA revised its policy language to support the development, testing and use of cost-effective on-board technologies that improve vehicle safety, driver performance, productivity, vehicle maintenance, and management. TCA supports federal motor vehicle safety standards for those technologies that have a proven significant safety benefit and a reasonable cost.
The newly approved policy changes take effect immediately.
"With these three new policies, TCA is prepared to address the regulatory initiatives that are certain to be presented in the near future," said Chris Burruss, TCA’s president. "We are now in a position to help shape the rulemakings and put the wishes of our membership at the forefront of whatever new laws are created."